Northern Europe vs United Republic of Tanzania: Proportion of the target population who received the final dose of
Northern Europe
76.0%
in 2024
United Republic of Tanzania
94.0%
in 2024
Northern Europe rank
2nd
United Republic of Tanzania rank
5th
Proportion of the target population who received the final dose of over time
- Northern Europe
- United Republic of Tanzania
How they compare
United Republic of Tanzania currently reports 94.0% against 76.0% in Northern Europe, a difference of 18.0%.
That makes United Republic of Tanzania's figure about 1.2 times Northern Europe's.
The two have swapped places 1 time across 7 shared years of data; in 2018 it was Northern Europe ahead.
Northern Europe ranks 2nd and United Republic of Tanzania ranks 5th of 35 groups.
Northern Europe has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Northern Europe | United Republic of Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 79.0% | 33.0% | 46.0% | Northern Europe |
| 2020s | 72.0% | 71.8% | 0.2% | Northern Europe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Northern Europe or United Republic of Tanzania?
- United Republic of Tanzania, at 94.0% against 76.0% in Northern Europe as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Northern Europe and United Republic of Tanzania?
- 18.0%, with United Republic of Tanzania ahead.
- How many years of comparable data are there for Northern Europe and United Republic of Tanzania?
- 7 years are reported by both, from 2018 to 2024.
- How do Northern Europe and United Republic of Tanzania rank globally for proportion of the target population who received the final dose of?
- Northern Europe ranks 2nd and United Republic of Tanzania ranks 5th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.